p75NTR antagonist THX-B increases mature nerve growth factor secretion by bladder cells through decreased activity of matrix metalloproteinase-9
Molecular and Cellular Endocrinology · 2025
DOI: 10.1016/j.mce.2025.112487 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2025. Verfasst von Aalya Hamouda und 5 weiteren Autor:innen. Beteiligte Einrichtung: Lady Davis Institute, McGill University, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Matrix Metalloproteinase 9, Nerve Growth Factor, Urinary Bladder, Receptors, Nerve Growth Factor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Canadian Urological Association.
Abstract (Originalsprache)
In urine samples from an aging female cohort with overactive bladder syndrome (OAB), the proteolytic activity of matrix metalloproteinase-9 (MMP-9), an enzyme which degrades mature NGF, was elevated and associated with low levels of nerve growth factor (NGF). Given that a substantial portion of urine constituents originate from bladder cellular processes, we examined the synthesis of NGF and MMP-9 in rat urothelial (UROs) and smooth muscle (SMCs) cells in culture. NGF and proNGF were found expressed and released by both cell types while UROs were the major source of secreted MMP-9. THX-B, a highly specific p75NTR antagonist, decreased the expression of MMP-9 resulting in increased mature NGF levels in culture medium of UROs while displaying minor effects on SMCs. Likewise, CRISPR-cas9 genomic deletion of MMP-9 potently increased mature NGF levels in both cell types. On the other hand, THX-B decreased the synthesis and release of α2 Macroglobulin (α2M), a protein that stabilizes proNGF in UROs but increased it in SMCs. THX-B also increased the activity of enzymes furin and matrix metalloproteinase-7 (MMP-7), that convert proNGF to mature NGF in UROs, yielding a net increase in mature NGF and a decrease of proNGF. We conclude that p75NTR is involved in the control of proNGF and mature NGF secretion from bladder cells through modulation of proteolytic activities. Since neurotrophins and binding to their receptors are relevant to pathologies, inhibition of p75NTR by THX-B may be exploited in a therapeutic strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lady Davis Institute, McGill University, Montreal, Quebec, Canada.
- Lady Davis Institute, McGill University, Montreal, Quebec, Canada; Urology Department, Jewish General Hospital, Montreal, Quebec, Canada. Electronic address: lysanne.campeau@mcgill.ca.
Förderung
- Canadian Urological Association
Zitieren
APA
Hamouda, A., Sirmakesyan, S., Hajj, A., Cammisotto, P. G., Saragovi, H. U., & Campeau, L. (2025). p75NTR antagonist THX-B increases mature nerve growth factor secretion by bladder cells through decreased activity of matrix metalloproteinase-9. Molecular and Cellular Endocrinology. https://doi.org/10.1016/j.mce.2025.112487
Vancouver
Hamouda A, Sirmakesyan S, Hajj A, Cammisotto PG, Saragovi HU, Campeau L. p75NTR antagonist THX-B increases mature nerve growth factor secretion by bladder cells through decreased activity of matrix metalloproteinase-9. Molecular and Cellular Endocrinology. 2025. doi:10.1016/j.mce.2025.112487
BibTeX
@article{Hamouda2025,
author = {Hamouda, Aalya and Sirmakesyan, Stephanie and Hajj, Aya and Cammisotto, Philippe G and Saragovi, H Uri and Campeau, Lysanne},
title = {p75NTR antagonist THX-B increases mature nerve growth factor secretion by bladder cells through decreased activity of matrix metalloproteinase-9},
journal = {Molecular and Cellular Endocrinology},
year = {2025},
doi = {10.1016/j.mce.2025.112487}
}
EUVIMED